CTN :43794355
16 Feb, 2026
NA
Tender For supply of medicine and iv fluids - dextrose 5% inj ffs, dextrose 5% glass bottle inj, dextrose 10% inj ffs, dextrose 25% inj ffs, sodium chloride inj 0.45% ffs, sodium chloride inj 0.9% ffs, sodium chloride inj 0.9% glass bottle, 3% hypertonic saline inj ffs, sodium chloride 0.9 % and dextrose 5gm inj ffs, compound ringer lactate inj, multiple electrolytes & dextrose injection an cl
ass="text-red-selected">typean> i ip (electrolyte p
injection) ffs, 6% hydroxyethyl st
arch solution
inj ffs/pouch, multipile electrolyte solution (crystollide sol for pl
asm
a repl
acement)
inj an class="text-red-selected">typean> 1 ffs/pouch, m
annitol ip 20%
inj, m
annitol ip 10% &
amp; glycerine 10%
inj, sodium bic
arbon
ate
inj 8.4% w/v, pot
assium chloride
inj 15mg/1ml, cefpodoxime 200 mg pot
assium cl
avul
an
ate 125 mg c
ap/t
ab, linezolid 600 mg c
ap/t
ab,
amoxycillin pot
assium cl
avul
an
ate 500 mg + cl
avul
anic
acid 125 mg + l
actob
acillus 60 million spores c
ap, rif
aximin 400 mg c
ap/t
ab, cefixime 100mg/5ml or
al suspension, doxycycline 100 mg/vi
al
inj, levoflox
acin 500mg/100 ml
inj, ciproflox
acin
inj 200 mg/100 ml ffs, moxiflox
acin
inj 400mg/100 ml ffs, v
ancomycin 500 mg/vi
al
inj, linezolid 600mg/300ml
inj, minocycline 100 mg
inj, teicopl
anin 400 mg
inj, povidone iodine cle
ansing scrub 7.5% solution, glut
ar
aldehyde 2.4% solution, cetrimide 3% w/v chlorhexidine 1.5% w/v, silver sulph
adi
azine 10mg/gm cre
am, fr
amycetin sulph
ate 1% w/w cre
am, l
ansopr
azole or
ally disintegr
ating 15 mg t
ab, r
abepr
azole 20 mg domperidone 30 mg sr t
ab, p
antopr
azole 40 mg
inj, l
actulose syp 10gm/15ml, polyethylene glycol 13.125mg/25ml + sodium chloride 350.7 mg/25ml + sodium bic
arbon
ate 178.5 mg/25 ml + pot
assium chloride 46.6 mg/25 ml, bis
acodyl 5mg t
ab, metoclopr
amide
inj 10mg/2ml, ond
ansetron
inj 2mg/ml, doxyl
amine 10mg + pyridoxine 10 mg t
ab, ondensetron 2mg/5ml syrup, metronid
azole
injection 500 mg/ 100ml ffs, spores of poly
antibiotic resist
ant b
acillus cl
ausii 2 billion/5 ml, etofylline 84.7 mg/ml &
amp; theophylline 25.3 mg/ml
inj, s
albut
amol sulp. 2.5mg/2.5ml in norm
al s
aline respir
ator sol., budesonide 1mg/2ml steroid nebulizing susp., ipr
atropium ip 500 mcg/2.5 ml levos
albut
amol 1.25 mg/2.5 ml respir
ator sol., formoterol 20 mcg/ 2ml budesonide 0.5 mg/ 2ml respir
ator susp., glycopyrronium 25 mcg/2ml inh
al
ation sol., n
acetyl cysteine 200mg/ml inh
al
ation sol., nitroglycerine controlled rele
ase 2.6 mg t
ab, metoprolol 25 mg extended rele
ase t
ab, l
abet
alol 100 mg t
ab, l
abet
alol
inj 5mg/ml, cilnidipine 10 mg t
ab, cilnidipine 10 mg + telmis
art
an 40 mg t
ab,
amiod
arone hydrochloride ip 50 mg/ml
inj, dop
amine 40 mg/ml
inj, dobut
amine 50mg/ml
inj, nor
adren
aline 1mg/ml
inj,
adren
aline 1mg/ml
inj,
acet
azol
amide 250 mg t
ab, torsemide 10 mg t
ab, et
amsyl
ate 250 mg + tr
anex
amic
acid 500 mg t
ab, tr
anxemic
acid
inj 500mg/5ml,
aqueous solution of h
aemoco
agul
ase isol
ated from venom of bothrops j
ar
ar
ac
a 1cu/ml,
aqueous solution of h
aemoco
agul
ase isol
ated from bothrops
atrox or bothrops j
ar
ar
ac
a 0.2cu/ml topic
al solution, hep
arin sodium 5000 iu/ml
inj, hep
arin sodium 50 iu/gm gel, tr
am
adol
inj 100mg/2 ml, p
ar
acet
amol 250mg/5ml or
al suspension, p
ar
acet
amol
inj infusion 1000mg/100ml ffs, diclofen
ac sodium 75mg/ml iv (
aques)
inj, e
ach enteric-co
ated t
ablet cont
ains 1,00,000
armour units of enzym
atic
activity. supplied by
a purified concentr
ate which h
as specific trypsin
and chymotrypsin
activity in
a r
atio of
approxim
ately six to one., n
aproxen 500 mg t
ab, phenytoin
inj 100mg/2ml, sodium v
alpro
ate
inj 100mg/ml, phenir
amine m
ale
ate 22.75mg/ml
inj, fexofen
adine hcl 120 mg + monteluk
ast 10 mg t
ab, defl
az
acort 6 mg t
ab, methylprednisolone sodium succin
ate 250 mg
inj, dex
ameth
asone
inj 8mg/2ml, hydrocortisone
inj 100mg/vi
al, lignoc
aine hydrochloride 21.3 mg/ml, sodium chloride 6.0 mg/ml
inj, lignoc
aine hydrochloride 21.3mg/ml with
adren
aline 0.005mg/ml
inj, lignoc
aine 2% jelly, lignoc
aine without preserv
ative (e
ach ml cont
ain lignoc
aine hydrochloride 21.3 mg, sodium chloride 6.0 mg)
inj, bupiv
ac
aine hydrochloride 5 mg/ml (he
avy), dextrose 80 mg/ml
inj, bupiv
ac
aine hyd